ArticleCell discovery2018

ADRB2 polymorphism Arg16Gly modifies the natural outcome of heart failure and dictates therapeutic response to β-blockers in patients with heart failure.

Jin Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.